Latest Articles

Publication Date
Guggenheim reiterates Absci stock rating on endometriosis trial delay By Investing.com - Investing.com Nigeria

Guggenheim reiterates Absci stock rating on endometriosis trial delay By Investing.com Investing.com Nigeria

Published: Sept. 28, 2026, 6:34 a.m.
Guggenheim reiterates Absci stock rating on endometriosis trial delay By Investing.com - Investing.com India

Guggenheim reiterates Absci stock rating on endometriosis trial delay By Investing.com Investing.com India

Published: Sept. 28, 2026, 6:25 a.m.
E2F1 downregulation promotes lipid droplet accumulation and endometriosis development through impaired MGLL-mediated lipid mobilization.

Endometriosis is a common gynecological disease in which lipid metabolic dysregulation has been increasingly implicated. However, the specific metabolic changes in ectopic lesions and stromal cells remain poorly understood. It …

Published: Sept. 28, 2026, midnight
Comparison of perioperative outcomes between laparoscopy and robotic-assisted surgery in the surgical treatment of endometriosis: a retrospective study.

Minimally invasive surgery is the gold standard for the surgical treatment of endometriosis. However, controversy remains in the literature regarding the perioperative benefits of robotic-assisted surgery compared to laparoscopic surgery, …

Published: Sept. 28, 2026, midnight
Use of symptom-reporting tools to support endometriosis identification and management in primary care: a realist synthesis.

Endometriosis affects 5-10% of women of reproductive age and is associated with chronic pain, infertility and reduced quality of life. Symptom Reporting Tools (SRTs) may support identification and management in …

Published: Sept. 28, 2026, midnight
A Case of Deep Infiltrating Endometriosis Undergoing Malignant Transformation to Müllerian Adenosarcoma: Case Report and Literature Review.

Müllerian adenosarcoma (MA) is a rare malignant tumor of the female reproductive system. Owing to the limited number of clinical cases and the absence of characteristic clinical manifestations, its clinical …

Published: Sept. 27, 2026, midnight
Simvastatin and Primaquine Identified as Potential Endometriosis Therapeutics via a Novel Epithelial-Stromal Assembloid Drug Screening Assay.

Endometriosis is an estrogen-driven, inflammatory disorder affecting ~10% of menstruators, causing severe pain. Current treatments that reduce estrogen or inflammation have inconsistent efficacy and poor tolerability. Therapies identified via drug-repositioning …

Published: Sept. 27, 2026, midnight
Shortening the Endometriosis Diagnostic Pathway: A Narrative Review and Research Agenda.

Endometriosis is often diagnosed several years after the first onset of symptoms; however, the duration of this delay may vary depending on the population studied, the assessment starting point, and …

Published: Sept. 26, 2026, midnight
Endometriosis symptoms, signs and treatment updates - Daily Express

Endometriosis symptoms, signs and treatment updates Daily Express

Published: Sept. 25, 2026, 6:03 a.m.
Endometriosis symptoms, signs and treatment updates - express.co.uk

Endometriosis symptoms, signs and treatment updates express.co.uk

Published: Sept. 25, 2026, 6:03 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!